Spectral Med Inc's stock price saw a modest increase today amidst a backdrop of mixed performance over the past month.
Spectral Med Inc (EDT.TO) experienced a price increase of 1.74% in today's trading session, closing at C$1.17. However, the stock has faced a decline of 0.85% over the past week and a more significant drop of 12.03% in the last month. Investors are closely monitoring developments following recent updates from the company regarding its regulatory journey with the FDA and financial performance.
Advertisement
Spectral Med Inc
EDT.TO
EDT.TO
Spectral Med Inc
WealthAwesomeMarket cap
$343.46M
52W high
$1.65
52W low
$1.03
1W change
-0.85%
Beta
0.18
Analyst Price Targets
Based on analyst covering EDT · as of Sep 17, 2026
Wall Street analysts forecast EDT stock price to rise 169.2% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$3.15
+169.2% Upside
Current Price
C$1.17
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on EDT's historical volatility
30-Day Vol
41.9%
Annualized
90-Day Vol
31.1%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.98
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$1.10 | C$0.95 – C$1.27 |
| 60 trading days | C$1.04 | C$0.85 – C$1.27 |
| 90 trading days | C$0.98 | C$0.76 – C$1.26 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Despite today's uptick, the overall trend in Spectral Med's stock price reflects a challenging period, with significant declines year-to-date. Investors should consider the implications of the recent FDA meeting and financial results while evaluating the company's future potential.
C$1.17 closing price reflects a 1.74% increase today.
The stock's 52-week range of C$1.03 to C$1.65 indicates it is currently trading at approximately 23% of its range, suggesting potential volatility ahead.
Bull case
The recent update from the FDA regarding the PMA application for Toraymyxin™ suggests a favorable regulatory outlook since no additional clinical trials were requested. This could speed up the product's path to market and potentially boost revenue prospects.
Bear case
The stock's performance has been disappointing, with a year-to-date decline of over 15%. Additionally, the company reported a negative return on equity and a profit margin of 0.0%, raising concerns about its financial health and operational efficiency.
Recent Price Action
Advertisement
Spectral Med Inc's stock price closed at C$1.17 today, reflecting a 1.74% increase. However, the stock has seen a decline of 0.85% over the past week and a more notable drop of 12.03% in the last month. Year-to-date, the stock is down 15.22%, indicating a challenging environment for investors.
Company News and Regulatory Updates
Recent headlines highlight the company's updates following an in-person 100-Day Meeting with the FDA regarding the PMA application for Toraymyxin™ (PMX). The FDA did not request additional clinical trials, which may indicate a smoother regulatory path ahead. Additionally, the company provided updates on its second-quarter financial results, showcasing ongoing initiatives and financial performance.
Technical Picture
From a technical perspective, Spectral Med's stock is currently trading below its 50-day moving average of C$1.32 and 200-day moving average of C$1.35, indicating a bearish trend. The stock's 52-week range is C$1.03 to C$1.65, with the current price at approximately 23% of this range. The stock has a low beta of 0.18, suggesting it is less volatile compared to the broader market. Recent trading volume was 68,634 shares, which is 0.23 times the 20-day average volume of 59,266 shares.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
